7th July 2020

Senior Appointment At Creo

Chepstow-based Creo Medical Group has appointed a new chief commercial officer.

Non-executive director David Woods will start in the role from 1 August 2020. He has extensive experience in the med-tech sector and joins the company in his full-time executive role based in the US.

Woods has worked across gastroenterology, general and orthopaedic surgery, pulmonology and ear nose and throat. The company also believes his track record and market understanding will benefit the Creo team “at a crucial time when the company is moving from early clinical adoption to global commercialisation expansion”.

“I am very fortunate to have worked with a company as great as PENTAX Medical for more than two decades and to have worked with such terrific people,” said Woods. “It is certainly an experience where I have learned so much.

“Making the decision to leave was incredibly difficult, but I am enormously excited by the opportunity that Creo presents as we see increased commercial momentum from Creo’s first products and the commercial launch of a wider suite of medical devices that will radically change the way endoscopists and surgeons treat patients worldwide.”

A president of sales, service and commercial operations has also been appointed in both the US and the Asia-Pacific regions, while senior hires have been made for US sales, service and commercial operations, wider EMEA sales, global marketing and product management.